Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 6
Submit an article Journal homepage
610
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Why R-CHOP + X is not enough: lessons learned and next steps in the mission to improve frontline therapy for diffuse large B-cell lymphoma

Hua-Jay J. Chernga Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8266-8447
ORCID Icon &
Jason Westinb Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-1824-2337
ORCID Icon
Pages 1302-1312 | Received 22 Oct 2020, Accepted 15 Dec 2020, Published online: 06 Jan 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jurui Ge, Yaqin Xia, Zhenchang Sun, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Xudong Zhang, Zhaoming Li, Feifei Nan, Wenjuan Wan, Duo Xu, Jiayin Ding, XiaoRui Fu & Mingzhi Zhang. (2022) Improving outcomes in limited-stage de novo CD5+ DLBCL: systemic approaches with consolidative radiation. Leukemia & Lymphoma 63:6, pages 1369-1374.
Read now

Articles from other publishers (2)

Jason Westin, R. Eric Davis, Lei Feng, Fredrick Hagemeister, Raphael Steiner, Hun Ju Lee, Luis Fayad, Loretta Nastoupil, Sairah Ahmed, Alma Rodriguez, Michelle Fanale, Felipe Samaniego, Swaminathan P. Iyer, Ranjit Nair, Yasuhiro Oki, Nathan Fowler, Michael Wang, Man Chun John Ma, Francisco Vega, Timothy McDonnell, Chelsea Pinnix, Donna Griffith, Yang Lu, Sanjit Tewari, Ryan Sun, David W. Scott, Christopher R. Flowers, Sattva Neelapu & Michael R. Green. (2023) Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. Journal of Clinical Oncology 41:4, pages 745-755.
Crossref
Ajay Major, Edward R. Scheffer Cliff, Daniel A. Ermann, Urshila Durani & David A. Russler‐Germain. (2022) Frontline polatuzumab vedotin for diffuse large B‐cell lymphoma: A survey of clinician impressions. eJHaem 3:3, pages 930-935.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.